Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bindarit + Irbesartan in Diabetic Nephropathy
NCT01109212Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Mar 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bindarit in diabetic nephropathy (DN), sponsored by Angelini Pharma. Started Mar 2007; status: completed.
02
Drugs
bindarit
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01109212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109212.